102 results
Page 3 of 6
424B5
uf074
7 Jan 21
Prospectus supplement for primary offering
4:16pm
8-K
EX-99.1
x86xca5u
10 Nov 20
Clearside Biomedical Announces Third Quarter 2020 Financial Results and Provides Corporate Update
4:15pm
8-K
EX-99.1
1ih6ua8n 01fg82jaa
10 Aug 20
Clearside Biomedical Announces Second Quarter 2020 Financial Results and Provides Corporate Update
4:15pm
424B5
1hlvmi1ba8
22 May 20
Prospectus supplement for primary offering
5:07pm
8-K
EX-99.1
siwy5uoc1fjv1th007af
8 May 20
Clearside Biomedical Announces First Quarter 2020 Financial Results
7:15am
DEFA14A
j96eht y1
29 Apr 20
Additional proxy soliciting materials
7:02am
8-K
x19j tff4
28 Apr 20
Clearside Biomedical Revises NDA Resubmission Timeline and XIPERE™ Commercial Partnership with Bausch Health
7:15am
8-K
EX-99.1
eslmoj7kj 130
28 Apr 20
Clearside Biomedical Revises NDA Resubmission Timeline and XIPERE™ Commercial Partnership with Bausch Health
7:15am
8-K
EX-99.1
8hmuljy7h1d
8 Apr 20
Other Events
8:01am